Lentiviral vector-mediated delivery of short hairpin RNA results in persistent knockdown of gene expression in mouse brain.

Abstract:

:RNA interference (RNAi) is an evolutionarily conserved mechanism of posttranscriptional gene-specific silencing. For in vivo applications, RNAi has been hampered until recently by inefficient delivery methods and by the transient nature of the gene suppression. Lentiviral vectors (LVs) hold great promise for gene therapeutic applications, pharmaceutical target validation, and functional genomics because stable gene transfer is mediated both in dividing and nondividing cells. We have used a lentiviral vector-based system for RNAi. We produced human immunodeficiency virus type 1-derived LVs encoding a short hairpin RNA specific for enhanced green fluorescent protein (EGFP) mRNA that were capable of inhibiting EGFP expression in mammalian cells. EGFP knockdown persisted after multiple passages of the cells. Of particular interest, our RNAi LVs were equally effective in suppression and prevention of EGFP expression after stereotactic injection in adult mouse brain. Therefore, we believe that the use of LVs for stable RNAi in brain will become a powerful aid to probe gene function in vivo and for gene therapy of diseases of the central nervous system.

journal_name

Hum Gene Ther

journal_title

Human gene therapy

authors

Van den Haute C,Eggermont K,Nuttin B,Debyser Z,Baekelandt V

doi

10.1089/104303403322611809

keywords:

subject

Has Abstract

pub_date

2003-12-10 00:00:00

pages

1799-807

issue

18

eissn

1043-0342

issn

1557-7422

journal_volume

14

pub_type

杂志文章
  • Construction of a double recombinant adenovirus vector expressing a heterodimeric cytokine: in vitro and in vivo production of biologically active interleukin-12.

    abstract::Interleukin-12 (IL-12) is a heterodimeric cytokine that plays an important role in the development of cellular immunity. Clinical applications for this lymphokine include resolution of infectious disease, cancer immunotherapy, and boosting cellular immunity in AIDS patients. When using IL-12 and other cytokines therap...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.1996.7.3-333

    authors: Bramson J,Hitt M,Gallichan WS,Rosenthal KL,Gauldie J,Graham FL

    更新日期:1996-02-10 00:00:00

  • Direct comparison of steady-state marrow, primed marrow, and mobilized peripheral blood for transduction of hematopoietic stem cells in dogs.

    abstract::The optimal stem cell source for stem cell gene therapy has not been defined. Most gene transfer studies have used peripheral blood or marrow repopulating cells collected after administration of granulocyte colony-stimulating factor and stem cell factor (G-CSF/SCF). For clinical applications, however, growth factor ad...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/104303403322542329

    authors: Thomasson B,Peterson L,Thompson J,Goerner M,Kiem HP

    更新日期:2003-11-20 00:00:00

  • Reproducible high yields of recombinant adeno-associated virus produced using invertebrate cells in 0.02- to 200-liter cultures.

    abstract::The large amounts of recombinant adeno-associated virus (rAAV) vector needed for clinical trials and eventual commercialization require robust, economical, reproducible, and scalable production processes compatible with current good manufacturing practice. rAAV produced using baculovirus and insect cells satisfies the...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.2010.250

    authors: Cecchini S,Virag T,Kotin RM

    更新日期:2011-08-01 00:00:00

  • Novel SRESPHP peptide mediates specific binding to primary medullary thyroid carcinoma after systemic injection.

    abstract::The efficient and specific introduction of genes into cancer cells in vivo remains a major challenge for current gene therapy modalities. Peptides possess appropriate properties to serve as tumor-targeting agents. Thus, finding new cancer-selective peptides directing gene transfer to neoplastic cells by reducing trans...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.2005.16.1267

    authors: Böckmann M,Hilken G,Schmidt A,Cranston AN,Tannapfel A,Drosten M,Frilling A,Ponder BA,Pützer BM

    更新日期:2005-11-01 00:00:00

  • Transfection and expression of MnSOD cDNA decreases tumor malignancy of human oral squamous carcinoma SCC-25 cells.

    abstract::Overexpression of human manganese-containing superoxide dismutase (MnSOD) activity has been demonstrated to suppress malignancy in human melanoma and breast carcinoma cells in vitro and in vivo. To study its effects on human oral squamous carcinoma cells, stable transfection and expression of MnSOD in SCC-25 cells hav...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.1997.8.5-585

    authors: Liu R,Oberley TD,Oberley LW

    更新日期:1997-03-20 00:00:00

  • Novel oncolytic agent GLV-1h68 is effective against malignant pleural mesothelioma.

    abstract::Malignant pleural mesothelioma (MPM) is a fatal disease with a median survival of less than 14 months. For the first time, a genetically engineered vaccinia virus is shown to produce efficient infection, replication, and oncolytic effect against MPM. GLV-1h68 is a replication-competent engineered vaccinia virus carryi...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.2008.036

    authors: Kelly KJ,Woo Y,Brader P,Yu Z,Riedl C,Lin SF,Chen N,Yu YA,Rusch VW,Szalay AA,Fong Y

    更新日期:2008-08-01 00:00:00

  • FUT-175, a synthetic inhibitor of the complement pathway, protects against the inactivation of infectious retroviruses by human serum.

    abstract::Serum-induced inactivation of retroviruses is the most critical limitation for in vivo gene transfer therapy. To solve this problem, we searched for reagents that protect retroviruses from inactivation. The effects of the protease inhibitors FOY-007 and FOY-305 and of an inhibitor of the complement pathway FUT-175, al...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.1997.8.13-1575

    authors: Miyao Y,Ikenaka K,Kishima H,Tamura M,Nakamura K,Kurumi M,Hayakawa T,Shimizu K

    更新日期:1997-09-01 00:00:00

  • Characterization of lentiviral vector-mediated gene transfer in adult mouse brain.

    abstract::Lentiviral vectors are promising tools for gene transfer into the central nervous system. We have characterized in detail transduction with human immunodeficiency virus type 1 (HIV-1)-derived vectors encoding enhanced green fluorescent protein (eGFP) in the adult mouse brain. Different brain regions such as the striat...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/10430340252899019

    authors: Baekelandt V,Claeys A,Eggermont K,Lauwers E,De Strooper B,Nuttin B,Debyser Z

    更新日期:2002-05-01 00:00:00

  • A sensitive cell-based assay to measure the doxycycline concentration in biological samples.

    abstract::Doxycycline (DOX) is widely used as a pharmacological agent and as an effector molecule in inducible gene expression systems. For most applications, it is important to determine whether the DOX concentration reaches the level required for optimal efficacy. We developed a sensitive bioassay for measuring the DOX concen...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.2008.182

    authors: Kleibeuker W,Zhou X,Centlivre M,Legrand N,Page M,Almond N,Berkhout B,Das AT

    更新日期:2009-05-01 00:00:00

  • Ocular cell transfection with the human basic fibroblast growth factor gene delays photoreceptor cell degeneration in RCS rats.

    abstract::Based on the K8/JTS-1-mediated transfection technique, we developed an in vivo protocol for an efficient transfer of plasmid DNA to ocular cells. As determined with condensed plasmids containing reporter genes for either beta-galactosidase (pcDNA-lacZ) or enhanced green fluorescent protein (pREP-EGFP), the immortalize...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/10430340050129495

    authors: Neuner-Jehle M,Berghe LV,Bonnel S,Uteza Y,Benmeziane F,Rouillot JS,Marchant D,Kobetz A,Dufier JL,Menasche M,Abitbol M

    更新日期:2000-09-01 00:00:00

  • Combined immunotherapy and antiangiogenic therapy of cancer with microencapsulated cells.

    abstract::An alternative form of gene therapy involves immunoisolation of a nonautologous cell line engineered to secrete a therapeutic product. Encapsulation of these cells in a biocompatible polymer serves to protect these allogeneic cells from host-versus-graft rejection while recombinant products and nutrients are able to p...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.2004.15.945

    authors: Cirone P,Bourgeois JM,Shen F,Chang PL

    更新日期:2004-10-01 00:00:00

  • Electrophoretic component of electric pulses determines the efficacy of in vivo DNA electrotransfer.

    abstract::Efficient DNA electrotransfer can be achieved with combinations of short high-voltage (HV) and long low voltage (LV) pulses that cover two effects of the pulses, namely, target cell electropermeabilization and DNA electrophoresis within the tissue. Because HV and LV can be delivered with a lag up to 3000 sec between t...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.2005.16.1194

    authors: Satkauskas S,André F,Bureau MF,Scherman D,Miklavcic D,Mir LM

    更新日期:2005-10-01 00:00:00

  • Safety, tolerability, and lack of antibody responses after administration of a PfCSP DNA malaria vaccine via needle or needle-free jet injection, and comparison of intramuscular and combination intramuscular/intradermal routes.

    abstract::Introduction of a new vaccine requires choosing a delivery system that provides safe administration and the desired level of immunogenicity. The safety, tolerability, and immunogenicity of three monthly 2.5-mg doses of a PfCSP DNA vaccine were evaluated in healthy volunteers as administered intramuscularly (IM) by nee...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/10430340260201644

    authors: Epstein JE,Gorak EJ,Charoenvit Y,Wang R,Freydberg N,Osinowo O,Richie TL,Stoltz EL,Trespalacios F,Nerges J,Ng J,Fallarme-Majam V,Abot E,Goh L,Parker S,Kumar S,Hedstrom RC,Norman J,Stout R,Hoffman SL

    更新日期:2002-09-01 00:00:00

  • Direct intratumoral injection of an adenovirus expressing interleukin-12 induces regression and long-lasting immunity that is associated with highly localized expression of interleukin-12.

    abstract::Mice bearing breast tumors were treated with a single dose of an adenovirus expressing interleukin-12 (AdmIL-12.1) injected intratumorally, which produced regressions in greater than 75% of the treated tumors; approximately one-third of the animals remained tumor free. Complete regression was associated with immunity ...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.1996.7.16-1995

    authors: Bramson JL,Hitt M,Addison CL,Muller WJ,Gauldie J,Graham FL

    更新日期:1996-10-20 00:00:00

  • Enhanced ganciclovir killing and bystander effect of human tumor cells transduced with a retroviral vector carrying a herpes simplex virus thymidine kinase gene mutant.

    abstract::Gene transfer of the herpes simplex virus thymidine kinase (TK) gene associated with ganciclovir (GCV) treatment can lead to death of TK-expressing cells, and of neighboring TK- cells because of the bystander effect. Thus, a small proportion of TK+ cells in a tumor can lead to its complete regression after GCV treatme...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/10430340050083298

    authors: Qiao J,Black ME,Caruso M

    更新日期:2000-07-20 00:00:00

  • Novel role of kallistatin in protection against myocardial ischemia-reperfusion injury by preventing apoptosis and inflammation.

    abstract::Kallistatin is a serine proteinase inhibitor that has been shown to reduce joint swelling and to inhibit inflammation in a rat model of arthritis. In this study, we investigated the effect and mechanisms of kallistatin on cardiac function after myocardial ischemia-reperfusion (I/R) injury. The human kallistatin gene i...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.2006.17.1201

    authors: Chao J,Yin H,Yao YY,Shen B,Smith RS Jr,Chao L

    更新日期:2006-12-01 00:00:00

  • Reciprocal enhancement of gene transfer by combinatorial adenovirus transduction and plasmid DNA transfection in vitro and in vivo.

    abstract::The addition of replication-defective recombinant adenovirus to plasmid transfection (termed here "adenofection") has been shown to increase plasmid transgene expression in limited studies. Similarly, the addition of cationic liposomes to adenovirus increases adenovirus-mediated gene transduction (termed here "lipoduc...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/10430349950017059

    authors: Dunphy EJ,Redman RA,Herweijer H,Cripe TP

    更新日期:1999-09-20 00:00:00

  • Rapid production of clinical-grade gammaretroviral vectors in expanded surface roller bottles using a "modified" step-filtration process for clearance of packaging cells.

    abstract::Production of clinical-grade gammaretroviral vectors for ex vivo gene delivery requires a scalable process that can rapidly generate large amounts of vector supernatant, clear large numbers of residual packaging cells with minimal decreases in vector titer, and satisfy all current regulatory guidelines regarding produ...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.2010.064

    authors: Feldman SA,Goff SL,Xu H,Black MA,Kochenderfer JN,Johnson LA,Yang JC,Wang Q,Parkhurst MR,Cross S,Morgan RA,Cornetta K,Rosenberg SA

    更新日期:2011-01-01 00:00:00

  • Immunity to adeno-associated virus-mediated gene transfer in a random-bred canine model of Duchenne muscular dystrophy.

    abstract::Recombinant adeno-associated virus (rAAV)-mediated gene transfer has shown promise for treating diseases in various animal models including the mdx mouse model of Duchenne muscular dystrophy (DMD). In many cases, however, preclinical studies in inbred mice have not successfully predicted human clinical responses. To a...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.2006.093

    authors: Wang Z,Allen JM,Riddell SR,Gregorevic P,Storb R,Tapscott SJ,Chamberlain JS,Kuhr CS

    更新日期:2007-01-01 00:00:00

  • Enhanced Transduction of Macaca fascicularis Hematopoietic Cells with Chimeric Lentiviral Vectors.

    abstract::Recent marketing approval for genetically engineered hematopoietic stem and T cells bears witness to the substantial improvements in lentiviral vectors over the last two decades, but evaluations of the long-term efficacy and toxicity of gene and cell therapy products will, nevertheless, require further studies in nonh...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.2018.179

    authors: Sii-Felice K,Castillo Padilla J,Relouzat F,Cheuzeville J,Tantawet S,Maouche L,Le Grand R,Leboulch P,Payen E

    更新日期:2019-10-01 00:00:00

  • Escherichia coli-cloned CFTR loci relevant for human artificial chromosome therapy.

    abstract::Classical gene therapy for cystic fibrosis has had limited success because of immune response against viral vectors and short-term expression of cDNA-based transgenes. These limitations could be overcome by delivering the complete genomic CFTR gene on nonintegrating human artificial chromosomes (HACs). Here, we report...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.2009.225

    authors: Rocchi L,Braz C,Cattani S,Ramalho A,Christan S,Edlinger M,Ascenzioni F,Laner A,Kraner S,Amaral M,Schindelhauer D

    更新日期:2010-09-01 00:00:00

  • lacZ transgenic rats tolerant for beta-galactosidase: recipients for gene transfer studies using lacZ as a reporter gene.

    abstract::Gene transfer of reporter genes may trigger immune responses against the heterologous protein resulting in shortening of gene expression and inflammation. We generated transgenic rats expressing the lacZ gene under the control of the human immunodeficiency virus type 1 (HIV-1) long-terminal repeat (LTR) (HIV-lacZ) to ...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/104303402760128603

    authors: Ménoret S,Aubert D,Tesson L,Braudeau C,Pichard V,Ferry N,Anegon I

    更新日期:2002-07-20 00:00:00

  • Producing recombinant adeno-associated virus in foster cells: overcoming production limitations using a baculovirus-insect cell expression strategy.

    abstract::Establishing pharmacological parameters, such as efficacy, routes of administration, and toxicity, for recombinant adeno-associated virus (rAAV) vectors is a prerequisite for gaining acceptance for clinical applications. In fact, even a therapeutic window, that is, the dose range between therapeutic efficacy and toxic...

    journal_title:Human gene therapy

    pub_type: 杂志文章,评审

    doi:10.1089/hum.2009.092

    authors: Virag T,Cecchini S,Kotin RM

    更新日期:2009-08-01 00:00:00

  • Long-term efficacy after [E1-, polymerase-] adenovirus-mediated transfer of human acid-alpha-glucosidase gene into glycogen storage disease type II knockout mice.

    abstract::Glycogen storage disease type II (GSD-II) is a lethal, autosomal recessive metabolic myopathy caused by a lack of acid-alpha-glucosidase (GAA) activity in the cardiac and skeletal muscles. Absence of adequate intralysosomal GAA activity results in massive amounts of glycogen accumulation in multiple muscle groups, res...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/104303401750195917

    authors: Ding EY,Hodges BL,Hu H,McVie-Wylie AJ,Serra D,Migone FK,Pressley D,Chen YT,Amalfitano A

    更新日期:2001-05-20 00:00:00

  • Optimized adeno-associated virus (AAV)-protein phosphatase-5 helper viruses for efficient liver transduction by single-stranded AAV vectors: therapeutic expression of factor IX at reduced vector doses.

    abstract::Abstract Our studies have shown that coinjection of conventional single-stranded adeno-associated virus 2 (ssAAV2) vectors carrying the enhanced green fluorescent protein (EGFP) gene with self-complementary (sc) AAV2-T cell protein tyrosine phosphatase (TC-PTP) and scAAV2-protein phosphatase-5 (PP5) vectors resulted i...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.2009.100

    authors: Jayandharan GR,Zhong L,Sack BK,Rivers AE,Li M,Li B,Herzog RW,Srivastava A

    更新日期:2010-03-01 00:00:00

  • Sustained expression of high levels of human factor IX from human cells implanted within an immunoisolation device into athymic rodents.

    abstract::Immunoisolation of allogeneic cells within a membrane-bound device is a unique approach for gene therapy. We employed an immunoisolation device that protects allograft, but not xenograft, cells from destruction, to implant a human fibroblast line (MSU 1.2) in athymic rodents. Cells, transduced with the MFG-human facto...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.1998.9.6-879

    authors: Brauker J,Frost GH,Dwarki V,Nijjar T,Chin R,Carr-Brendel V,Jasunas C,Hodgett D,Stone W,Cohen LK,Johnson RC

    更新日期:1998-04-10 00:00:00

  • Cone-Specific Promoters for Gene Therapy of Achromatopsia and Other Retinal Diseases.

    abstract::Adeno-associated viral (AAV) vectors containing cone-specific promoters have rescued cone photoreceptor function in mouse and dog models of achromatopsia, but cone-specific promoters have not been optimized for use in primates. Using AAV vectors administered by subretinal injection, we evaluated a series of promoters ...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.2015.130

    authors: Ye GJ,Budzynski E,Sonnentag P,Nork TM,Sheibani N,Gurel Z,Boye SL,Peterson JJ,Boye SE,Hauswirth WW,Chulay JD

    更新日期:2016-01-01 00:00:00

  • Mitochondrial gene therapy augments mitochondrial physiology in a Parkinson's disease cell model.

    abstract::Neurodegeneration in Parkinson's disease (PD) affects mainly dopaminergic neurons in the substantia nigra, where age-related, increasing percentages of cells lose detectable respiratory activity associated with depletion of intact mitochondrial DNA (mtDNA). Replenishment of mtDNA might improve neuronal bioenergetic fu...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.2009.023

    authors: Keeney PM,Quigley CK,Dunham LD,Papageorge CM,Iyer S,Thomas RR,Schwarz KM,Trimmer PA,Khan SM,Portell FR,Bergquist KE,Bennett JP Jr

    更新日期:2009-08-01 00:00:00

  • Adenovirus-mediated transfer of an Na+/K+-ATPase beta1 subunit gene improves alveolar fluid clearance and survival in hyperoxic rats.

    abstract::Pulmonary edema is cleared via active Na(+) transport by alveolar epithelial Na(+)/K(+)-ATPases and Na(+) channels. Rats exposed to acute hyperoxia have a high mortality rate, decreased Na(+)/K(+)-ATPase function, and decreased alveolar fluid clearance (AFC). We hypothesized that Na(+)/K(+)-ATPase subunit gene overexp...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/104303400750035753

    authors: Factor P,Dumasius V,Saldias F,Brown LA,Sznajder JI

    更新日期:2000-11-01 00:00:00

  • Direct in vivo gene transfer to airway epithelium employing adenovirus-polylysine-DNA complexes.

    abstract::Adenovirus-polylysine-DNA complexes were evaluated for their capacity to accomplish direct in vivo gene transfer to airway epithelium employing a rodent model. Binary complexes containing transferrin or adenovirus, or combination complexes containing both transferrin and adenovirus, were evaluated. The highest in vitr...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.1993.4.1-17

    authors: Gao L,Wagner E,Cotten M,Agarwal S,Harris C,Rømer M,Miller L,Hu PC,Curiel D

    更新日期:1993-02-01 00:00:00